From: The safety of PolyGlycopleX® (PGX®) as shown in a 90-day rodent feeding study
Parameter (units) | Control | 1.25% | 2.5% | 5.0% |
---|---|---|---|---|
Males | ||||
Volume (mL) | 3.0 ± 1.5 | 4.0 ± 1.7 | 6.3 ± 4.6 | 6.4 ± 3.3a |
Specific Gravity | 1.074 ± 0.02 | 1.060 ± 0.017 | 1.054 ± 0.025 | 1.045 ± 0.018b |
pH | 6.2 ± 0.3 | 6.4 ± 0.3 | 6.6 ± 0.3b | 7.1 ± 0.5b |
Urobilinogen (EU/dL) | 0.6 ± 0.4 | 0.4 ± 0.4 | 0.4 ± 0.3 | 0.5 ± 0.4 |
Total Protein (mg/dL) | 876+683 | 808 ± 279 | 745 ± 412 | 457 ± 346 |
Females | ||||
Volume (mL) | 2.9 ± 3.3 | 4.0 ± 2.7 | 1.0 ± 1.0 | 6.8 ± 2.9a |
Specific Gravity | 1.055 ± 0.026 | 1.042 ± 0.017 | 1.070 ± 0.011 | 1.027 ± 0.008b |
pH | 6.0 ± 0.0 | 6.2 ± 0.4 | 6.1 ± 0.2 | 6.9 ± 0.2a |
Urobilinogen (EU/dL) | 0.3 ± 0.3 | 0.3 ± 0.3 | 0.4 ± 0.4 | 0.2 ± 0.0 |
Total Protein (mg/dL) | 258 ± 245 | 196 ± 374 | 111 ± 66 | 61 ± 46a |